Artiva Biotherapeutics, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Artiva Biotherapeutics, Inc. Common Stock's balance sheet done over the years? Its assets were worth $105,114,000 last year. 254% of Artiva Biotherapeutics, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $267,129,000.
Debt to Assets
| 2023 | 105114000 | 267.12M | 254.13% |
|---|
ARTV Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 53.50M |
Short term investments | 23.46M |
Net receivables | 1.75M |
Inventory | 0 |
Other current assets | 1.09M |
Total current assets | 79.82M |
Non-current assets: | |
Property, Plant and Equipment | 24.64M |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 650K |
Total non-current assets | 25.29M |
Total assets | 105.11M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 3.59M |
Total current liabilities | 12.22M |
| Non-current liabilities: | |
Long term debt | 13.31M |
Deferred tax | 0 |
Other non-current liabilities | 241.58M |
Total non-current liabilities | 254.90M |
Total liabilities | 267.12M |